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Sarah Ratzel1 and Sara B. Cullinan2Alu Elements in the Driver’s Seat
Boone et al., page 143
Although copy-number variants (CNVs) are known to
contribute to a range of Mendelian and complex disor-
ders, our understanding of their molecular origins
remains incomplete. Just as some elements render partic-
ular regions of the genome susceptible to errors at the sin-
gle-nucleotide level, some loci appear to be especially
prone to CNV formation. Previous reports have impli-
cated Alu elements in driving recombination-mediated
CNV formation at several loci, including SPAST, but tech-
nological limitations have hindered the type of in-depth
analyses that are required for drawing clear mechanistic
insights. Now, Boone et al. have mapped the breakpoint
junctions of over 50 SPAST CNVs at nucleotide resolu-
tion, providing evidence that the genomic architecture
of this locus predisoposes to a variety of CNV alleles,
including several that generate chimeric transcripts. A
better understanding of the phenotypic consequences
brought about by the range of CNVs generated at this
locus should prove helpful in both the diagnosis and
the treatment of spastic paraplegia. More broadly, these
findings add support to the notion that Alu elements
possess inherent genome-destabilizing properties. Just
how pervasive this activity is and what the consequences
for human health are will no doubt be the focus of many
future research endeavors.DeNovoMutations Aren’t Always what They Seem
Campbell et al., page 173
Although mosaicism can explain apparently de novo,
recurrent disease in families, it is unclear how frequently
mosaicism contributes to apparently de novo CNVs at a
larger population level. To determine whether more sensi-
tive detection methods could identify parental mosaicism
as a source of apparently de novo CNVs, Campbell et al.
screened 100 families with children harboring rare dele-
tions. Using PCR designed for each individual breakpoint
identified in these children, the authors detected low levels
of somatic mosaicism in four of the families, suggesting
that a substantial number of apparently de novo CNVs
are inherited from mosaic parents. To better understand
the results of this screen, they developed a probabilistic
model that predicts that somatic individuals in whom1Scientific Editor, AJHG; 2Deputy Editor, AJHG
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tablished harbor 7–8 orders of magnitude more mutant
gametes than the average individual. Clearly, these results
have implications for family planning. Oftentimes, more
intensive testing is not necessarily suggested for parents
of a child with a single de novo mutation. This study hints
that it might be beneficial to test parents for the specific
allele identified in the child to more rigorously determine
whether low-level parental mosaicism could be a contrib-
uting factor. As noninvasive prenatal testing improves,
the application of this strategy to maternal plasma could
be especially advantageous.Every Exome Has Clinically Useful Incidental
Findings
Tabor et al., page 183
One of the most hotly debated topics in returning
incidental findings from whole-genome and exome
sequencing relates to determining how useful these find-
ings might be for an individual. Evidence suggests that,
in general, people are interested in receiving findings
that they can use in making healthcare and lifestyle
choices. However, there is little information about how
many incidental findings with a defined clinical utility
(e.g., an established therapeutic intervention) a given
exome might contain. In this study, Tabor et al. analyzed
exome sequencing data from approximately 6,500 individ-
uals from the NHLBI Exome Sequencing Project to eval-
uate the frequency of pathogenic variants with clinical
utility in each individual and the curation required for
delivering these findings to an individual. To evaluate a
range of diseases and traits, the study focused on 39 genes
commonly included in newborn-screening programs, 17
genes associated with age-related macular degeneration,
and 14 genes that influence drug response. From these
genes, over 10,000 variants were identified, and almost
400 variants were determined to be pathogenic by manual
curation based on information from literature. On average,
each person carried approximately 15 risk alleles and had a
carrier burden of 0.57 for severe recessive disorders of
childhood. These data suggest that every individual under-
going clinical exome sequencing most likely has variants
of clinical utility. This study hints at both the potential
for this information tomake dramatic changes inmedicine
and the need to develop standard practices and tools fory of Human Genetics. All rights reserved.
ican Journal of Human Genetics 95, 127–128, August 7, 2014 127
discussing and delivering these results to an extent that is
reasonable and useful for individuals.pQTLs Are an Independent Source of Phenotypic
Diversity
Hause et al., page 194
Many investigations of complex traits have identified vari-
ants that influence mRNA levels—expression quantitative
trait loci (eQTLs)—and assume that these effects are
mirrored in protein accumulation. However, very few
studies have directly evaluated this assumption because of
the limitations of large-scale protein-quantification tech-
nologies. In this study, Hause et al. used micro-western
arrays to quantify nearly 400 transcription factor levels in
Yoruba lymphoblastoid cell lines from HapMap and evalu-
ated the relationship between genome-wide genetic varia-
tion and mRNA and protein levels. Using this approach,
they identified 12 cis and 160 trans protein-level QTLs
(pQTLs). Although cis eQTLs are often pQTLs, it is not the
case that pQTLs are associated with mRNA expression.
Additionally, many pQTLs overlap SNPs associated with
complex traits and therefore might provide additional
insight into the functional implication of these variants
in disease. Together, these results suggest that the effects
of genetic variation contributing to differential mRNA
expression are buffered in protein accumulation.Moreover,
pQTLs might independently affect phenotypic diversity.128 The American Journal of Human Genetics 95, 127–128, August 7Because this study focused on transcription factors, it will
be interesting to see how these findings apply to different
subsets of proteins and the proteome in general.A Genetic Finding for AFND
Smith et al., page 235
Acromelic frontonasal dysostosis (AFND) is a rare disorder
characterized by brain and limb malformations, along
with intellectual disability. Phenotype-informed candi-
date-gene approaches have failed to identify causative mu-
tations; moreover, the mode of inheritance has remained
unclear. Now, Smith et al. have identified an identical,
recurrent mutation in ZSWIM6 as being causative for
AFND. Little is known about ZSWIM6: its encoded protein
contains a domain (SWIM) that is predicted to have both
DNA-binding and protein-protein-interaction properties,
but no functional characterization has been carried out.
Expression and localization profiles in mouse and fish are
consistent with the human phenotype, and preliminary
work supports the hypothesis that aberrant activation of
hedgehog signaling might be at play. Lending further
support to this idea, the database DECIPHER includes
several individuals (lacking the AFND phenotype) who
harbor heterozygous deletions spanning ZSWIM6. Future
biochemical and cell biological work should help to
delineate the role of ZSWIM6, and perhaps also its family
members, in key developmental pathways., 2014
